Live Breaking News & Updates on Ericj Duncavage|Page 2

 E-Mail
IMAGE: A new study from Washington University School of Medicine in St. Louis shows that whole genome sequencing is at least as accurate and often better than conventional genetic tests that.
view more 
Credit: ERIC DUNCAVAGE
For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive treatment typically hinges on a set of lab tests to identify genetic changes. Some of these tests rely on technology that was invented more than 60 years ago and has been used clinically for the past three decades.
Now, a new study from Washington University School of Medicine in St. Louis shows that whole genome sequencing is at least as accurate and often better than conventional genetic tests that help determine the treatment for a patient s blood cancer. Genome sequencing technology continuously is decreasing in cost and recently reached a level similar to that of conventiona ....

Ericj Duncavage , Mollyc Schroeder , Peter Campbell , Davidh Spencer , School Of Medicine , National Center , Siteman Cancer Center At Barnes , National Cancer Institute , Cancer Center , Wellcome Sanger Institute In Cambridge , Washington University School Of Medicine , Siteman Cancer Center , Translational Sciences , Mcdonnell Genome Institute , Washington University , Illumina Inc , Alvinj Siteman Cancer Research Fund , Department Of Pathology Immunology , Molecular Pathology Laboratory , Washington University School , New England Journal , Mcdonnell Genome , Barnes Jewish Hospital , Siteman Cancer , Wellcome Sanger Institute , Advancing Translational Sciences ,